To examine whether pentamidine initiates an anti-tumor immune response by activating T cells through blockade of tumor-derived PD-L1, we measured the population of helper T cells (TH) and cytotoxic T cells in peripheral blood and the tumor microenvironment by flow cytometry. The gene discussed is CD274; the disease is neoplasm.